AHA Coding Clinic® for ICD-9 - 2009 Issue 4; VOLUMES 1 & 2 NEW/REVISED CODES
Endometrial Intraepithelial Neoplasia
Effective October 1, 2009, code 621.3 has been expanded to uniquely report benign endometrial hyperplasia (621.34) and endometrial intraepithelial neoplasia [EIN] (621.35). Recent studies have shown that genuine premalignant lesions are mutation-bearing monoclonal neoplasms, and computerized image analysis has defined new histologic features for their accurate diagnosis. Pathologists and gynecologists are increasingly using a practically oriented disease classification that distinguishes the benign hormonal effects of unopposed estrogens (benign hyperplasia) from emergent precancerous lesions (endometrial intraepithelial neoplasia [EIN]) through the use of non-overlapping terminology and discrete criteria. The separation of largely polyclonal proliferations that result from a...
Subscribe or sign in to view the full article.
Article Overview
This article covers an October 1, 2009 ICD-9-CM update related to endometrial hyperplasia terminology, including the separation of benign hyperplasia from endometrial intraepithelial neoplasia (EIN). It is relevant to pathology, gynecology, and medical coders who need to understand how the article frames the clinical terminology and the associated classification changes. The material also notes related exclusions and the broader context of how provider terminology affects code assignment.
Why This Topic Matters
The article helps readers understand a diagnosis coding revision that introduced more specific endometrial hyperplasia categories. That distinction affects how provider wording is interpreted and how related uterine conditions are classified.
Article Sections
-
Clinical overview of endometrial hyperplasia and EIN
Introduces the clinical distinction between benign endometrial hyperplasia and endometrial intraepithelial neoplasia, with discussion of classification concepts used by pathology and gynecology.
-
ICD-9-CM code revision details
Summarizes the coding changes effective in 2009 and the updated structure within the uterine disorder category.
-
Code assignment notes and exclusions
Presents the coding framework referenced in the article, including related exclusions and the instruction to base assignment on provider terminology.
What You Will Learn
- How the article distinguishes benign hyperplasia from EIN at a high level
- What ICD-9-CM update timeframe the article discusses
- Which classification area the article says was expanded
- How provider terminology is described as relevant to code assignment
- What related exclusions are mentioned in the article
Who Should Read This
- Medical coders
- Pathologists
- Gynecologists
- Clinical documentation staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com